Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus (Q59656664)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jou-Wei Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Li-Chiu Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K Arnold Chan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1462-1472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

Epidemiological aspects of neoplasms in diabetes

17 January 2020

cites work

1 reference

7 January 2021

Diabetes and cancer: a consensus report.

1 reference

7 January 2021

1 reference

7 January 2021

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

7 January 2021

The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study

1 reference

7 January 2021

Cancer statistics, 2009

1 reference

7 January 2021

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

1 reference

7 January 2021

Physical Activity and Cancer Prevention???Data from Epidemiologic Studies

1 reference

7 January 2021

American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity

1 reference

7 January 2021

A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish

1 reference

7 January 2021

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells

1 reference

7 January 2021

PPARgamma as a therapeutic target for tumor angiogenesis and metastasis

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention

1 reference

7 January 2021

Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive

1 reference

7 January 2021

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

1 reference

7 January 2021

Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials

1 reference

7 January 2021

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

1 reference

7 January 2021

Cancer risks in thiazolidinedione users compared to other anti-diabetic agents

1 reference

7 January 2021

Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus

1 reference

7 January 2021

Principles of epidemiological research on adverse and beneficial drug effects.

1 reference

7 January 2021

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

1 reference

7 January 2021

The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

1 reference

7 January 2021

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1.

1 reference

7 January 2021

Thiazolidinedione anti-cancer activity: Is inhibition of microtubule assembly implicated?

1 reference

7 January 2021

Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan

1 reference

7 January 2021

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways

1 reference

7 January 2021

Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.

1 reference

7 January 2021

Hepatocellular carcinoma in Taiwan

1 reference

7 January 2021

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

1 reference

7 January 2021

Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development

1 reference

7 January 2021

Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.

1 reference

7 January 2021

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

1 reference

7 January 2021

Pegylated interferon -2a versus standard interferon -2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised study

1 reference

7 January 2021

Metformin as an antitumor agent in cancer prevention and treatment

1 reference

7 January 2021

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

7 January 2021

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma in lung cancer: defining specific versus "off-target" effectors

1 reference

7 January 2021

Review article: Thiazolidinediones and heart failure

1 reference

7 January 2021

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone

1 reference

7 January 2021

The PROactive Study: pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes

1 reference

7 January 2021

Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?

1 reference

7 January 2021

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22135104%20AND%20SRC:MED&resulttype=core&format=json